Abstract
Curcumin has various pharmacological activities such as anti-inflammatory, antioxidant, antimicrobial and antitumor activity. However, its use has been limited due to its poor solubility in water and minimal systemic bioavailability. Thus, we developed curcumin-delivering heparin-based nanoparticles and evaluated the inhibition effects of osteoclastogenesis by curcumin-delivering heparin nanoparticles (Cur-HD NPs). Cur-HD NPs were dispersed well in aqueous solution by forming self-assembled nanoparticles and showed sustained release of curcumin. In vitro studies, HD NPs facilitated intracellular delivery of curcumin into macrophages and osteoclasts, and thus, Cur-HD NPs effectively inhibited osteoclastogenesis in a dose-dependent manner by suppressing tartrate-resistant acid phosphatase (TRAP) activity and TRAP-positive multinucleated cells as well as by reducing the expression of osteoclast marker genes (i.e., TRAP and nuclear factor of activated T cells cytoplasmic 1 (NFATc1)). Furthermore, Cur-HD NPs markedly stimulated apoptosis of osteoclasts. Therefore, we hope that Cur-HD NPs will be useful nanodrugs for the treatment of bone-related diseases.
Similar content being viewed by others
References
Y. Fujikawa, A. Sabokbar, S. D. Neale, I. Itonaga, T. Torisu, and N. A. Athanasou, Bone, 28, 261 (2001).
U. Feige, Ann. Rheum. Dis., 60Suppl 3, iii81 (2001).
H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, and T. Suda, Proc. Natl. Acad. Sci. U.S.A., 95, 3597 (1998).
B. R. Wong, R. Josien, S. Y. Lee, M. Vologodskaia, R. M. Steinman, and Y. Choi, J. Biol. Chem., 273, 28355 (1998).
H. Hsu, D. L. Lacey, C. R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H. L. Tan, G. Elliott, M. J. Kelley, I. Sarosi, L. Wang, X. Z. Xia, R. Elliott, L. Chiu, T. Black, S. Scully, C. Capparelli, S. Morony, G. Shimamoto, M. B. Bass, and W. J. Boyle, Proc. Natl. Acad. Sci. U.S.A., 96, 3540 (1999).
L. Galibert, M. E. Tometsko, D. M. Anderson, D. Cosman, and W. C. Dougall, J. Biol. Chem., 273, 34120 (1998).
B. G. Darnay, V. Haridas, J. Ni, P. A. Moore, and B. B. Aggarwal, J. Biol. Chem., 273, 20551 (1998).
H. Ichikawa and B. B. Aggarwal, Clin. Cancer Res., 12, 662 (2006).
S. Shishodia, G. Sethi, and B. B. Aggarwal, Ann. N. Y. Acad. Sci., 1056, 206 (2005).
T. S. Huang, S. C. Lee, and J. K. Lin, Proc. Natl. Acad. Sci. U.S.A., 88, 5292 (1991).
A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, Blood, 101, 1053 (2003).
S. Hanazawa, A. Takeshita, S. Amano, T. Semba, T. Nirazuka, H. Katoh, and S. Kitano, J. Biol. Chem., 268, 9526 (1993).
A. C. Bharti, Y. Takada, and B. B. Aggarwal, J. Immunol., 172, 5940 (2004).
A. Goel, S. Jhurani, and B. B. Aggarwal, Mol. Nutr. Food Res., 52, 1010 (2008).
B. B. Aggarwal, C. Sundaram, N. Malani, and H. Ichikawa, Adv. Exp. Med. Biol., 595, 1 (2007).
H. H. Tonnesen, H. de Vries, J. Karlsen, and G. B. van Henegouwen, J. Pharm. Sci., 76, 371 (1987).
R. A. Sharma, H. R. McLelland, K. A. Hill, C. R. Ireson, S. A. Euden, M. M. Manson, M. Pirmohamed, L. J. Marnett, A. J. Gescher, and W. P. Steward, Clin. Cancer Res., 7, 1894 (2001).
C. D. Lao, M. T. t. Ruffin, D. Normolle, D. D. Heath, S. I. Murray, J. M. Bailey, M. E. Boggs, J. Crowell, C. L. Rock, and D. E. Brenner, BMC Complement. Altern. Med., 6, 10 (2006).
K. Sou, B. Oyajobi, B. Goins, W. T. Phillips, and E. Tsuchida, J. Biomed. Nanotechnol., 5, 202 (2009).
D. Prajakta, J. Ratnesh, K. Chandan, S. Suresh, S. Grace, V. Meera, and P. Vandana, J. Biomed. Nanotechnol., 5, 445 (2009).
L. Mazzarino, L. F. Silva, J. C. Curta, M. A. Licinio, A. Costa, L. K. Pacheco, J. M. Siqueira, J. Montanari, E. Romero, J. Assreuy, M. C. Santos-Silva, and E. Lemos-Senna, J. Biomed. Nanotechnol., 7, 406 (2011).
Y. Gao, C. Wang, M. Sun, X. Wang, A. Yu, A. Li, and G. Zhai, J. Biomed. Nanotechnol., 8, 659 (2012).
P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, Mol. Pharm., 4, 807 (2007).
F. Kesisoglou, S. Panmai, and Y. Wu, Adv. Drug Deliv. Rev., 59, 631 (2007).
W. Wei, Y. Mu, X. Li, M. Gou, H. Zhang, S. Luo, K. Men, Y. Mao, Z. Qian, and L. Yang, J. Biomed. Nanotechnol., 7, 768 (2011).
K. Park, K. Kim, I. C. Kwon, S. K. Kim, S. Lee, D. Y. Lee, and Y. Byun, Langmuir, 20, 11726 (2004).
K. Park, G. Y. Lee, Y. S. Kim, M. Yu, R. W. Park, I. S. Kim, S. Y. Kim, and Y. Byun, J. Control. Release, 114, 300 (2006).
K. Park, Y. S. Kim, G. Y. Lee, R. W. Park, I. S. Kim, S. Y. Kim, and Y. Byun, Pharm. Res., 25, 2786 (2008).
A. V. Kabanov and V. A. Kabanov, Bioconjug. Chem., 6, 7 (1995).
Y. Lee, J. H. Nam, H. C. Shin, and Y. Byun, Circulation, 104, 3116 (2001).
I. Bleiberg, I. MacGregor, and M. Aronson, Thromb. Res., 29, 53 (1983).
Y. Igarashi, M. Y. Lee, and S. Matsuzaki, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 781, 345 (2002).
H. Takayanagi, Nat. Rev. Immunol., 7, 292 (2007).
M. C. Walsh, N. Kim, Y. Kadono, J. Rho, S. Y. Lee, J. Lorenzo, and Y. Choi, Annu. Rev. Immunol., 24, 33 (2006).
H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama, and T. Taniguchi, Dev. Cell, 3, 889 (2002).
H. Takatsuna, M. Asagiri, T. Kubota, K. Oka, T. Osada, C. Sugiyama, H. Saito, K. Aoki, K. Ohya, H. Takayanagi, and K. Umezawa, J. Bone Miner. Res., 20, 653 (2005).
T. Negishi-Koga and H. Takayanagi, Immunol. Rev., 231, 241 (2009).
D. J. Van Antwerp, S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma, Science, 274, 787 (1996).
Z. G. Liu, H. Hsu, D. V. Goeddel, and M. Karin, Cell, 87, 565 (1996).
K. Ozaki, H. Takeda, H. Iwahashi, S. Kitano, and S. Hanazawa, FEBS Lett., 410, 297 (1997).
K. Ozaki, Y. Kawata, S. Amano, and S. Hanazawa, Biochem. Pharmacol., 59, 1577 (2000).
M. López-Lázaro, Mol. Nutr. Food. Res., 52, S103 (2008).
J. Kang, J. Chen, Y. Shi, J. Jia, and Y. Zhang, Biochem. Pharmacol., 69, 1205 (2005).
J. K. Lin, Adv. Exp. Med. Biol., 59, 227 (2007).
National Toxicology Program, Natl.
National Toxicology Program, Natl. Toxicol. Program Tech. Rep. Ser., 427, 1 (1993).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors are equally contributed to this work.
The image from this article is used as the cover image of the Volume 22, Issue 6.
Rights and permissions
About this article
Cite this article
Yun, YP., Kim, S.E., Lee, J.Y. et al. Enhanced effects of osteoclastogenesis inhibition by curcumin-delivering heparin nanoparticles. Macromol. Res. 22, 647–656 (2014). https://doi.org/10.1007/s13233-014-2082-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13233-014-2082-1